Effect of chronic ethanol treatment on μ-opioid receptor function, interacting proteins and morphine-induced place preference

[1]  M. Brodie,et al.  Reversal of Dopamine D2 Agonist-Induced Inhibition of Ventral Tegmental Area Neurons by Gq-Linked Neurotransmitters Is Dependent on Protein Kinase C, G Protein-Coupled Receptor Kinase, and Dynamin , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[2]  M. Shibasaki,et al.  Actin dynamics in development of behavioral sensitization after withdrawal from long-term ethanol administration to mice. , 2012, Alcoholism, clinical and experimental research.

[3]  M. Shibasaki,et al.  Enhancement of histone acetylation in midbrain of mice with ethanol physical dependence and its withdrawal , 2011, Synapse.

[4]  Y. Uezono,et al.  Possible involvement of β‐endorphin in a loss of the coordinated balance of μ‐opioid receptors trafficking processes by fentanyl , 2011, Synapse.

[5]  M. Shibasaki,et al.  Upregulation of L‐type Cav1 channels in the development of psychological dependence , 2010, Synapse.

[6]  W. Dewey,et al.  The Effect of Protein Kinase C and G Protein-coupled Receptor Kinase Inhibition on Tolerance Induced by ␮-opioid Agonists of Different Efficacy , 2022 .

[7]  E. Drews,et al.  Modulation of alcohol and nicotine responses through the endogenous opioid system , 2010, Progress in Neurobiology.

[8]  S. Oldfield,et al.  Involvement of PKCα and G‐protein‐coupled receptor kinase 2 in agonist‐selective desensitization of µ‐opioid receptors in mature brain neurons , 2009, British journal of pharmacology.

[9]  C. Gianoulakis,et al.  Effect of acute ethanol administration on the release of opioid peptides from the midbrain including the ventral tegmental area. , 2009, Alcoholism, clinical and experimental research.

[10]  P. De Camilli,et al.  Selective saturation of slow endocytosis at a giant glutamatergic central synapse lacking dynamin 1 , 2008, Proceedings of the National Academy of Sciences.

[11]  Lan Ma,et al.  Phosphorylation state of mu-opioid receptor determines the alternative recycling of receptor via Rab4 or Rab11 pathway. , 2008, Molecular endocrinology.

[12]  J. Bettinger,et al.  Loss of RAB‐3/A in Caenorhabditis elegans and the mouse affects behavioral response to ethanol , 2008, Genes, brain, and behavior.

[13]  R. Spanagel,et al.  Neuropharmacology of alcohol addiction , 2008, British journal of pharmacology.

[14]  E. Kelly,et al.  Agonist‐selective mechanisms of GPCR desensitization , 2008, British journal of pharmacology.

[15]  Daniel A. Gschwend,et al.  Molecular modeling of G-protein coupled receptor kinase 2: Docking and biochemical evaluation of inhibitors , 2000, AAPS PharmSci.

[16]  A. Chappell,et al.  Chronic ethanol and withdrawal differentially modulate pre- and postsynaptic function at glutamatergic synapses in rat basolateral amygdala. , 2007, Journal of neurophysiology.

[17]  K. Krnjević,et al.  Effects of ethanol on midbrain neurons: role of opioid receptors. , 2007, Alcoholism, clinical and experimental research.

[18]  D. Rhie,et al.  Desensitization of somatostatin-induced inhibition of low extracellular magnesium concentration-induced calcium spikes in cultured rat hippocampal neurons , 2006, Brain Research.

[19]  T. Sotnikova,et al.  An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior , 2005, Cell.

[20]  M. Caron,et al.  Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. , 2004, Molecular pharmacology.

[21]  T. Sotnikova,et al.  Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Ferguson,et al.  Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. , 2003, Life sciences.

[23]  K. Mikoshiba,et al.  Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles , 2003, The Journal of cell biology.

[24]  E. Kelly,et al.  μ-Opioid Receptor Desensitization in Mature Rat Neurons: Lack of Interaction between DAMGO and Morphine , 2003, The Journal of Neuroscience.

[25]  M. Shibasaki,et al.  Changes in G‐protein activity mediated through the stimulation of dopamine and GABA B receptors in the mesolimbic dopaminergic system of morphine‐sensitized mice , 2003, Addiction biology.

[26]  M. Larsen,et al.  Cdk5 is essential for synaptic vesicle endocytosis , 2003, Nature Cell Biology.

[27]  P. Verbanck,et al.  Alcohol and withdrawal: from animal research to clinical issues , 2003, Neuroscience & Biobehavioral Reviews.

[28]  F. Holloway,et al.  Micro1-opioid antagonist naloxonazine alters ethanol discrimination and consumption. , 2003, Alcohol.

[29]  M. Narita,et al.  Intensification of the development of ethanol dependence in mice lacking dopamine D3 receptor , 2002, Neuroscience Letters.

[30]  Tomohiro Mori,et al.  Rational Design and Evaluation of New Lead Compound Structures for Selective βARK1 Inhibitors , 2002 .

[31]  Tomohiro Mori,et al.  Rational design and evaluation of new lead compound structures for selective betaARK1 inhibitors. , 2002, Journal of medicinal chemistry.

[32]  P. Greengard,et al.  Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5 , 2001, Nature.

[33]  M. Narita,et al.  Implications of the NR2B subunit-containing NMDA receptor localized in mouse limbic forebrain in ethanol dependence. , 2000, European journal of pharmacology.

[34]  P. Kalivas,et al.  Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies , 2000, Psychopharmacology.

[35]  M. Brodie,et al.  Ethanol directly excites dopaminergic ventral tegmental area reward neurons. , 1999, Alcoholism, clinical and experimental research.

[36]  M. Misawa,et al.  Different roles of μ-, δ- and κ-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress , 1999 .

[37]  M. Misawa,et al.  Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress. , 1999, European journal of pharmacology.

[38]  F. Weiss,et al.  Suppression of Ethanol-Reinforced Behavior by Naltrexone Is Associated with Attenuation of the Ethanol-Induced Increase in Dialysate Dopamine Levels in the Nucleus Accumbens , 1998, The Journal of Neuroscience.

[39]  M. Misawa,et al.  Involvement of μ- and δ-opioid receptors in the ethanol-associated place preference in rats exposed to foot shock stress , 1998, Brain Research.

[40]  M. Caron,et al.  Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. , 1998, Life sciences.

[41]  M. Misawa,et al.  Involvement of mu- and delta-opioid receptors in the ethanol-associated place preference in rats exposed to foot shock stress. , 1998, Brain research.

[42]  G. Aghajanian,et al.  Molecular and cellular basis of addiction. , 1997, Science.

[43]  A. Herz.  Endogenous opioid systems and alcohol addiction , 1997, Psychopharmacology.

[44]  P. Kalivas,et al.  The role of mesoaccumbens-pallidal circuitry in novelty-induced behavioral activation , 1995, Neuroscience.

[45]  E. Nestler,et al.  Molecular mechanisms of drug reinforcement and addiction. , 1995, Annual review of neuroscience.

[46]  M. Miwa,et al.  Pertussis toxin abolishes μ- and δ-opioid agonist-induced place perference , 1991 .

[47]  M. Misawa,et al.  Pertussis toxin abolishes mu- and delta-opioid agonist-induced place preference. , 1991, European journal of pharmacology.

[48]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[49]  B. Pitt.  Psychopharmacology , 1968, Mental Health.

[50]  T. Haley,et al.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. , 1957, British journal of pharmacology and chemotherapy.